Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Versicor, Inc. (now Pfizer)

Versicor Inc. was a biopharmaceutical company committed to discovering, developing and commercializing novel antifungal and antibiotic agents with distinct competitive advantages. The company was acquired by Vicouron, a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vital medicine for seriously ill patients. The company was later acquired by Pfizer in 2005.

Search Projects

  • Project Director, Combinatorial Chemistry